NCT05989620
- Conditions
- Cardiomyopathies, Cardiovascular Diseases, Cobblestone Lissencephaly, +70 more
- Locations
-
- Virginia Commonwealth University Richmond, Virginia, United States
Clinical trial condition
Muscular Dystrophy, Limb-Girdle, Type 2I
Explore clinical trials studying Muscular Dystrophy, Limb-Girdle, Type 2I. Study availability and eligibility vary by location and protocol.
11 public trials
2 recruiting studies
Muscular Dystrophy, Limb-Girdle, Type 2I trial results
NCT00313677
- Conditions
- Cobblestone Lissencephaly, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +17 more
- Locations
-
- University of Iowa, 200 Hawkins Drive Iowa City, Iowa, United States
Active, not recruiting
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
NCT05230459
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, FKRP, FKRP Mutation, +17 more
- Locations
-
- University of California - Irvine Irvine, California, United States
- University of Iowa Iowa City, Iowa, United States
- University of Kansas Medical Center Kansas City, Kansas, United States
- Kennedy Krieger Institute Baltimore, Maryland, United States
Active, not recruiting
Study of BBP-418 in Patients With LGMD2I
NCT04800874
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, LGMD2I, +8 more
- Locations
-
- Virginia Commonwealth University Richmond, Virginia, United States
Active, not recruiting
Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9
NCT07678775
- Conditions
- Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I), Muscular Dystrophy, Limb-Girdle, Type 2I
- Locations
-
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- University of California Irvine Medical Center Orange, California, United States
- University of Colorado Hospital (UCH) - Anschutz Medical Campus Aurora, Colorado, United States
- University of Florida Health Center for Pediatric Neuromuscular and Rare Diseases Gainesville, Florida, United States
Active, not recruiting
ATA-100 (Formerly GNT0006) Gene Therapy Trial in Patients With LGMDR9
NCT05224505
- Conditions
- LGMDR9, Muscular Dystrophy, Limb-Girdle, Type 2I
- Locations
-
- Rigshospitalet, University of Copenhagen Blegdamsvej 9 Copenhagen, Denmark
- Institute of Myology Pitié-Salpêtrière Hospital 47 Bd de l'Hôpital Paris, France
- Royal Victoria Infirmary Queen Victoria Road Level 6 Leazes Wing Newcastle upon Tyne, United Kingdom
Active, not recruiting
Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)
NCT05775848
- Conditions
- Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I), Muscular Dystrophy, Limb-Girdle, Type 2I
- Locations
-
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- University of California Irvine Irvine, California, United States
- University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
- University of Florida Gainsville, Florida, United States
NCT03842878
- Conditions
- LGMD2I, Muscular Dystrophy, Limb-Girdle, Type 2I
- Locations
-
- Pr John Vissing Copenhagen, Denmark
- Dr Tanya Stojkovic Paris, France
- Pr Volker Straub Newcastle, United Kingdom
Completed
Biomarker Development in LGMD2i
NCT04202627
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Limb Girdle Muscular Dystrophy, +8 more
- Locations
-
- University of California Irvine Irvine, California, United States
- University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
- University of Florida Gainesville, Florida, United States
- University of Iowa Iowa City, Iowa, United States
NCT02841267
- Conditions
- LGMD2I, Muscular Dystrophy, Limb-Girdle, Type 2I
- Locations
-
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc. Baltimore, Maryland, United States